Homburger advised Becton, Dickinson and Company (BD) in its acquisition of Straub Medical AG
On April 20, 2020, BD announced that it has completed the acquisition of Straub Medical AG, a privately-held company that develops and sells medical atherectomy and thrombectomy devices that treat PAD and Venous disease. BD welcomes more than 80 new associates who add valuable experience and expertise as well as key technologies.
This acquisition allows BD to immediately deliver advanced technologies in both atherectomy and thrombectomy and further enhances BD’s already strong portfolio of drug-coated, angio-plasty, and scoring balloons, stents, stent grafts, and CTO crossing products for the treatment of PAD and Venous disease.
The Homburger team advising BD in this transaction was led by partners Daniel Daeniker and Daniel Hasler and associate Karin Mattle (all Corporate / M&A) and included partner Stefan Oesterhelt and associate Marc Vogelsang (both Tax), Mirko Stiefel and junior associate Therry Lehmann (both Corporate / M&A), partner Luca Dal Molin and associate Katrina Frame (both IP / IT), partner Richard Stäuber and associate Sabrina Zimmermann (both Competition), partner Katrin Ivell (Compliance) and partner Claudia Suter (Private Clients).